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INTRODUCTION
Urological treatment of urinary calculi has changed much
in the past 20 yr. Various endourological treatment modali-
ties are available for urinary calculi; ureteroscopic lithotrip-
sy, shock wave lithotripsy (SWL), laparoscopic lithotomy,
and percutaneous nephrolithotomy. Despite the liberal use
of SWL, ureteroscopic lithotripsy is still the preferred treat-
ment modality for managing ureter stones at many hospitals
and achieves an immediate stone-free state in a high percent
of patients. In recent years, the advent of small caliber uretero-
scopes and advances in intraureteral lithotripsy have allowed
high rates of successful and safe endoscopic treatment of ureter-
al calculi (1-3). Currently available semirigid ureteroscopes
with a diameter of less than 7Fr and the flexible uretreroscopes
can usually be passed up the ureter without ureteral dilation,
thus, minimizing morbidity. 
Advances in intraureteral lithotripters such as holmium:
YAG laser or Freddy can yield better results. Compared with
laser lithotripters, pneumatic lithotripter is old-fashioned
and has some limitations of upward migration of stone frag-
ments and the lack of fragmentation into small particles. Un-
fortunately, pneumatic lithotripter had been the only avail-
able tool of ureteroscopic lithotripsy in our hospital for 12
yr. Of course, it is well known that pneumatic lithotripter
has some proven merits of safety and cost-effectiveness. We
respectively reviewed our experience of ureteroscopic lithotrip-
sy using Swiss Lithoclast. 
MATERIALS AND METHODS
From January 1996 to September 2007, 411 ureteral cal-
culi in 392 patients were treated in our institution with ure-
teroscopic lithotripsy using Swiss Lithoclast. Medical records
of 341 cases in 326 patients were available for use in this ret-
rospective study. Exclusion criteria were: radiolucent stone,
stone size >2 cm, access failure, failure to apply Swiss Litho-
clast. Fifteen patients had bilateral disease. Mean age of 326
patients was 48.1 yr (from 26 to 80). 
The 341 cases were divided into three groups according to
the stone location. Group 1 consisted of stones located above
the pelvic brim (upper), group 2 consisted of stones located
over the pelvic brim (mid) and group 3 consisted of stones
located below the pelvic brim (lower). The number of cases
in each group was 61 in group 1, 49 in group 2, and 231 in
group 3. The characteristics of 341 cases are shown on Table
1. There were no significant differences of baseline character-
istics including gender, age and stone diameter between the
three groups. 
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Ureteroscopic Lithotripsy Using Swiss Lithoclast for Treatment of
Ureteral Calculi: 12-Years Experience
Ureteroscopic lithotripsy using Swiss Lithoclast was performed in 411 cases from
January 1996 to September 2007 in a single hospital. Medical records of 341 cases,
in which Swiss Lithoclast was successfully applied, were available for this retrospec-
tive study. We used 9.5Fr and 10Fr Storz rigid ureteroscopes. A success was defined
as being free of stone-related symptoms and residual stones larger than 2 mm. Sixty
one stones were located in the upper ureter, 49 stones were in the mid ureter, and
231 stones were in the lower ureter. The overall success rate was 93.5%. The suc-
cess rate of upper ureter stone (80.3%) was significantly lower compared with those
of mid (93.8%) and lower (96.9%) ureter stones (P=0.001). The higher the calculi
was located within the ureter, the more chance of upward migration there was (P<
0.001). The success rate in male patients was lower than in female patients with-
out a statistical significance (P=0.068). The success rate decreased as the size of
the stone increased (P<0.001), and as the degree of hydronephrosis increased
(P=0.03). Perforation rates were 4.9%, 4.1%, and 2.6% from upper to lower ureter
stone group. Ureteroscopic lithotripsy using Swiss Lithoclast is a safe and useful
treatment modality for ureteral calculi. 
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The parameters used for comparison among the three groups
were success rate, stent indwelling, intraoperative ureteral
perforation. We also analyzed the success rates according to
gender of the patients, stone size, and degree of hydronephro-
sis. Our entire equipments for ureteroscopic lithotripsy con-
sisted of 9.5Fr, 10Fr Storz rigid ureteroscopes with 5Fr work-
ing channel, 5Fr foreign body forceps, stone basket, and Swiss
Lithoclast with three probes (1.6, 1, and 0.8 mm). Routine
biochemical analysis, blood count, urinalysis and culture of
urine were performed preoperatively. Intravenous pyelogram
or computed tomogram was taken to confirm the diagnosis
and determine the location and the size of stones. Prophy-
lactic antibiotics were injected intravenously in all patients.
The procedure was performed with the patients under either
general or spinal anesthesia as decided by anesthesiologists.
A safety guide wire was inserted into the ureter as a cysto-
scopic procedure. The ureteroscope was introduced via ureter-
al orifice with or without ureteral dilation. Ureteral dilation
was performed using metal dilator or balloon dilator as nec-
essary. Flow of irrigation was controlled by a valve attached
to the ureteroscope and accelerated with squeezing pump as
needed during operation. Lithoclast probes were passed through
the working channel, placed in contact with the calculi, and
stones were fragmented down to pieces smaller than 2 mm in
diameter under video monitoring and foot control switch.
Fragmented stones were removed out of the ureter as much as
possible using basket or forceps. 
A JJ stent (6 Fr 22, 24, 26 cm) was placed whenever decid-
ed necessary in cases of ureteral edema secondary to an impact-
ed calculus, ureteral injury, and upward migration of stone
fragments. A plain radiography of the kidneys, ureters and
bladder (KUB) was performed 2 weeks after surgery to assess
residual stone fragments. Success was defined as symptom-
free and no evidence of residual stones larger than 2 mm in
diameter, since stone particles less than 2 mm usually would
pass the ureter spontaneously. The outcome of ureteroscopic
lithotripsy was compared according to the location of calculi
within ureter (Group 1, 2, 3). All variables were expressed
as mean±standard deviation. The chi-square test, ANOVA
and Fisher’s exact test were used to compare parameters bet-
ween the different groups. P<0.05 was considered statisti-
cally significant. Statistical analysis was performed with com-




The overall success rate at 2 weeks postoperative day was
93.5% (Table 2). The success rates were different according
to the location of stone. The success rate of group 1 was 80.3%,
and those of group 2 and 3 were 93.8% and 96.9%, respec-
tively. The success rate of group 1 was significantly lower than
other two groups (P=0.001). Success rates of group 2 and
group 3 were not significantly different. The higher the cal-
culi located within ureter, the more chance of upward migra-
tion there was (P<0.001). The success rate in male patients
was lower than in female patients (91.6% vs. 96.9%), but
there was no statistical significance (P=0.068, Table 3). The













No. of cases 61 49 231 341
Male 39 27 148 214 0.488
Female 22 22 83 127
Age (yr) 46.9±11.2 50.4±9.7 48.3±11.4 48.1±11.5 0.410
Stone   10.9±4.5 8.7±4.3 8.8±4.2 9.1±4.3 0.213
diameter (mm)
Table 1. Baseline data of the subjects
*, group 2, group 3>group 1; 
� , group 1>gruop 2>group 3.
Upper (group 1) Parameters Middle (group 2) Lower (group 3) Total P value
No. of cases 61 49 231 341
Success  49 (80.3%) 46 (93.8%) 224 (96.9%) 319 (93.5%) 0.001*
Failure 12 (19.7%) 3 (6.2%) 7 (3.1%) 22 (6.5%)
Migrated stones 10 (16.4%) 4 (8.2%) 4 (1.7%) 18 (5.3%) <0.001
�
Perforation 2 (3.3%) 0 (0%) 2 (0.9%) 4 (1.2%) 0.148
Stent indwelling 41 (67.2%)  31 (63.3%)  140 (60.6%)  212 (62.2%) 0.630
Ureteral perforation 3 (4.9%) 2 (4.1%) 6 (2.6%) 11 (3.2%) 0.422
Lasting gross hematuria (>72 hr)  7 (11.4%) 5 (10.2%) 18 (7.8%) 30 (8.8%) 0.453
Pain requiring analgesics 30 (49.1%) 22 (44.9%) 98 (42.4%) 150 (44.0%) 0.633
Table 2. Results and complications according to stone location
Male Location Female P value
Upper ureter 29/39 (74.4%) 20/22 (90.9%) 0.1821
Middle  ureter 25/27 (92.6%) 21/22 (95.5%) 1.0000
Lower  ureter 142/148 (96.0%) 82/83 (98.8%) 0.4264
Total 196/214 (91.6%) 123/127 (96.9%) 0.0682
Table 3. Success rates according to gender and stone location692 Y.K. Hong and D.S. Park
0.001, Table 4), and as the degree of hydronephrosis increased
(P=0.03, Table 5). Residual stones larger than 2 mm were
noted in 22 cases at 2 weeks after surgery. Eighteen cases of
failure was due to upward migration of stones during lithotrip-
sy and the other four cases of failure was associated with inci-
dental ureteral perforation during lithotripsy. We failed to
fragment the stones completely in four cases out of eleven
ureteral perforations. Two failed patients were lost to follow-
up, and the other 20 failed patients reached stone-free state
with auxiliary SWL (15 cases) or medical expulsive therapy
(3 cases) or repeated ureteroscopic lithotripsy (2 cases). 
Stent indwelling 
The rate of stent indwelling was 67.2% (41/61) in group
1, 63.3% (31/49) in group 2 and 60.6% (140/231) in group
3 respectively. The overall rate of stent indwelling was 62.2%
(212/341) (Table 2). The indication of stent indwelling in-
cluded ureteral perforation, mucosal avulsion or marked ede-
ma, marked bleeding, impacted stone, residual stones, and
the surgeon’s preference. Ureteral stent was left in place for
2 to 8 weeks according to postoperative condition of the ureter.
Ureteral perforations were treated with stent indwelling for
4 to 8 weeks without open surgery. 
Complications (Table 2)
Ureteral perforation occurred in 11 patients (3.2%), and
the incidence was 4.9% in group 1, 4.1% in group 2, and
2.6% in group 3 respectively. The highest incidence was noted
in group 1, but the difference was not statistically significant.
Ureteral perforations occurred in eight men and three women
who had impacted stones with ureteral narrowing or kink-
ing, because guide wires could not pass the obstructed ureter
in such cases. Intraoperative ureteral perforation was managed
by indwelling a ureteral stent after stopping the procedure
as soon as possible. All patients who suffered from ureteral
perforations underwent intravenous pyelography 2 weeks after
removal of ureteral stent. There was no evidence of ureteral
stricture or extravasation of contrast material in any patient
with ureteral perforation. The most common postoperative
complications were pain requiring analgesics and gross hema-
turia lasting for more than 72 hr. In postoperative complica-
tions there was no difference of incidence between the three
groups. 
DISCUSSION
Means of ureteroscopic lithotripsy include ultrasound, elec-
trohydraulic, pneumatic, and laser. These instruments are
passed through the working channel of the ureteroscope to
fragment stones into extractable pieces. In choosing a spe-
cific lithotripter operators should take into account not only
the characteristics of the stone but also the potential adverse
events of the specific lithotripsy technique (4). Every device
has its advantages and limitations. Electrohydraulic lithotrip-
sy (EHL), the first intracorporeal option, was developed in
the 1950s (5). Stone fragmentation is achieved via an electri-
cal discharge through a fluid medium, causing a hydraulic
shockwave. Although some authors reported fragment rates
reaching up to 100% related to EHL, tissue trauma were
the main problem (6-9). Stone free rates of EHL for ureteral
calculi ranges from 85.3% to 100% and complication rates
ranges from below 10% to 45%. Compared with other ure-
teroscopic lithotripters, EHL has more complications includ-
ing ureteral perforation. 
Ultrasonic lithotripsy (USL) relies on rapid vibration of the
probe tip, which grinds the stone into fragments. USL requires
large-diameter instruments with a straight operating chan-
nel; therefore preoperative dilation of the intramural ureter
in necessary. This process prolongs the time required for the
procedure and increases the amount of ionizing radiation to
the patient. The reported stone-free rate following a single
treatment with USL ranges from 73.3% in a large scale study
(10) to 89.4% in a small study (8). According to a large scale
study, ureteral perforation requiring surgical correction oc-
curred in 0.65% (10). USL could be a safe and effective treat-
ment option for ureteral stones; however, other therapeutic
strategies should also be considered in patients with current-
ly identified risk factors associated with treatment failure fol-
lowing a single USL procedure. 
Holmium:YAG laser lithotripsy differs from prior genera-
tion lasers such as alexandrite, pulsed dye, and Q-switched
lasers. Older lithotripters had short pulse durations that de-
posited laser energy quickly, causing a high-energy vapor bub-
ble. This bubble subsequently collapsed, thereby fragment-
ing calculi through a ‘photoacoustic effect’ (11). In contrast,
the holmium:YAG laser has long pulse duration with a pear-
shaped bubble and fragmentation occurs through a ‘photother-
mal mechanism’ (11). The net result of this modality is small-
er fragmentation, and thereby less efficient/slower lithotrip-
<5 mm 5-10 mm >10 mm P value
Upper 2/2 (100.0%) 34/38 (89.5%) 13/21 (61.9%) 0.0323
Middle 9/9 (100.0%) 26/27 (96.3%) 11/13 (84.6%) 0.2507
Lower 56/57 (98.32%) 138/141 (97.9%) 30/33 (90.9%) 0.0981
Total 66/68 (97.1%) 198/206 (96.1%) 55/67 (82.1%) 0.0005    
Table 4. Success rates according to stone size and location
Mild HN Moderate HN Severe HN P value
Upper 27/32 (84.4%) 14/17 (82.4%) 8/12 (66.7%) 0.4296
Middle 28/29 (96.6%) 11/12 (91.7%) 7/8 (87.5%) 0.3606
Lower 126/128 (98.4%) 72/75 (96.0%) 26/28 (92.9%) 0.1747
Total 181/189 (95.8%) 97/104 (93.3%) 41/48 (85.4%) 0.0349
Table 5. Success rates according to degree of hydronephrosis
(HN) and stone location
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sy. However, the overriding major advantage is the holmium’s
ability to fragment all stone compositions (11). 
The Swiss Lithoclast (a pneumatic lithotripter), originally
developed at the University Teaching Hospital in Lausanne,
Switzerland, is based on a jackhammer principle (12). A pro-
jectile in the handpiece is propelled by compressed air through
the probe. The compressed air originates from a small gen-
erator that is connected to a dry, clean air supply. The ballis-
tic energy produced is conveyed to the probe base at a rate of
12 Hz (13). Continued impaction of the probe tip against
the stone results in stone breakage once the tensile forces of
the calculus are overcome. The metallic probe rods are avail-
able in five diameters: 0.8 mm, 1.0 mm, 1.6 mm, 2.0 mm,
and 3.5 mm. Pneumatic lithotripsy has the benefit of better
stone targeting and visualization than is possible with the
laser. Rapid flashes of light emanating from the laser and visu-
ally obscuring protective eyewear may interfere with target-
ing. Nevertheless, according to recent studies comparing
holmium:YAG laser with Swiss Lithoclast, holmium:YAG
laser has higher stone-free rate or fragmentation rate and less
complications (14-16). Stone free rate of holmium:YAG laser
ranged from 92% to 97% and complication rate was as low
as below 4%. On the other hand, stone free rate of pneumatic
lithotripsy ranged from 82% to 86% and complication rate
was 8% to 14% in these studies. Swiss Lithoclast had been
the only available tool of ureteroscopic lithotripsy in our hos-
pital for 12 yr, so we did not have a chance to compare it with
other treatment modalities including holmium:YAG laser.
It is well established that pneumatic lithotripter has merits
of safety and cost-effectiveness. Pneumatic lithotripter is very
effective on every stone composition including calcium oxalate
monohydrate and cystine stones (13), and it is rarely traumat-
ic to tissue and has a low complication rates (17-19). The rate
of successful fragmentation of ueteral calculi has wide spec-
trum from 70.7% to 96.8%, showing a trend of higher suc-
cess rate as the number of patient increases in each study and
as the follow-up time increases from the day of operation (14-
19). Our results are comparable with those of other studies
about pneumatic lithotripsy. The only appreciable disadvan-
tages of pneumatic lithotripsy are the limitation of probe rigid-
ity and the potential for proximal stone migration during
treatment. The overall rate of stone migration in this study
was 5.28%, and 16.4% of upper ureter stone cases failed due
to upward migration. The use of a suction device (Lithovac)
in conjunction with the Lithoclast or of occlusion devices
(basket, occlusion balloon catheter, Stone Cone) or occlusion
material (lidocaine jelly) decreases the migration rate (20-22).
We used a basket only in some indicated cases of upper ureter
stone during pneumatic lithotripsy. We did not have a flex-
ible ureteroscope, so we used SWL for migrated stones left
in renal collecting system. The reported rate of ureteral per-
foration and avulsion during ureteroscope is 0-4% (23), and
the rate of ureteral stricture was reported as 0.5% (24). The
rates of ureteral perforation (3.2%) and stricture formation
(0%) in this study are similar to or lower than these values. 
Ureteral stenting after ureteroscopic lithotripsy is a com-
mon practice to prevent postoperative complications such as
ureteral obstruction. Some investigator noted that uncompli-
cated ureteroscopy can be performed without routine stent-
ing with minimal patient discomfort and a low incidence of
postoperative complications (25, 26). Denstedt et al. report-
ed that patients, in whom a stent was not inserted, were not
at increased risk for complications and postoperative symp-
toms including flank pain after ureteroscopy compared with
those with a stent, and ureteral stenting after uncomplicat-
ed ureteroscopic stone fragmentation was no longer absolutely
necessary in all cases (27). We placed ureteral stent even when
ureteral injury was not remarkable to prevent postoperative
complications such as ureteral stricture. We believe that the
liberal use of stent in this study could lead a good result against
ureteral stricture.
In conclusion, pneumatic lithotripsy with Swiss Lithoclast
is an effective and safe treatment modality for ureter stones.
Its efficacy is reduced in case of large sized upper ureter stones
with marked hydronephrosis because of higher chance of stone
fragment migration during lithotripsy. 
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